Scientific Program

Scientific Program

To download the Scientific Program please click here >>

DiaObesity2017 Scientific Program


Wednesday 22 Nov 2017

Program:Pre-Summit Course: EASO OMTF (Obesity Management Task Force) Teaching Course in Obesity Management  
08:00-08:50Gathering & Light Refreshment
08:50-09:00Course Opening Nathalie Farpour-Lambert
Switzerland &Dror Dicker
Israel
09:00-09:30Obesity as a diseaseDror Dicker
Israel
09:30-10:00Childhood obesity as a chronic disease Nathalie Farpour-Lambert
Switzerland
10:00-10:30Motivational Interview – to Whom, When & How? Batya Kornboim
Israel
10:30-11:00Anti-Obesity medication – to Whom, When & How?Gabriella Segal Lieberman
Israel
11:00-11:30Gastroenterological tools for treating Obesity and Post Bariatric Surgery complicationsSigal Fishman
Israel
11:30-12:00Coffee Break/Commercial Exhibition
12:00-12:30Bariatric/Metabolic Surgery – to Whom, When & How?Hadar Spivak
Israel
12:30-13:00Post Bariatric Surgery TreatmentDror Dicker
Israel
13:00-13:30Evaluation & Questions/Answers & Course Summary
13:30-14:30Lunch
*** SUPPORTED BY NOVO NORDISK***

Program:DiaObesity Opening Plenary Session 
17:00-18:00Registration
18:00-18:40Opening of meeting Ministry of Health
Israel
18:40-19:00 STATE OF THE ART - Childhood Obesity - How big is the problem, and how much is it going to cost us? Nathalie Farpour-Lambert
Switzerland
19:00-19:40STATE OF THE ART - How should we change Diabetes treatment guidelines in light of the new evidence? Itamar Raz
Israel
19:40-20:00 STATE OF THE ART - Nutrigenetics of obesity- are we there yet? Ruth Birk
Israel
20:00-20:20 STATE OF THE ART - How close are we to mimicking the effects of bariatric surgery without the use of a knife? Carel le Roux
Ireland
20:20-22:00 Welcome Reception

Thursday 23 Nov 2017

Program:STATE OF THE ART : Big Data in DiaObesity  
O8:20-08:40STATE OF THE ART - What have we learned from Big Data -ObesityRan Balicer
Israel
08:40-09:00STATE OF THE ART - What have we learned from real world data in novel diabetes therapy?Avraham Karasik
Israel
Session 1:The brain as a target for obesity therapy:
09:00-09:30Functional neuroimaging in the development of novel anti-obesity interventionsMichael Stumvoll
Germany
09:30-10:00Exploiting the intra-nasal administration route for central delivery of insulin and other hormones in obesity therapy.Manfred Hallschmid
Germany
10:00-10:30Can we smell Obesity?Dror Dicker
Israel
10:30-11:00Obesity, dysglycemia and cognitive decline: Evidence-based and current clinical practice for a bi-directional relationshipTali Cukierman-Yaffe
Israel
11:00-11:30 Coffee Break/Commercial Exhibition/Abstract Exhibition
Session 2: New Frontiers in Diabetes Treatment
09:00-09:30 Combating the Residual Cardiovascular Risk: The Future is Here!Eran Leitersdorf
Israel
09:30-10:00Are all SGLT2 inhibitors created equal? From class effect to drug effect.Avivit Cahn
Israel
10:00-10:30Can we reduce mortality in all patients with type 2 diabetes? Lessons from the new studiesRoy Eldor
Israel
10:30-11:00Combination Therapy - Does it work better?Maya Ish-Shalom
Israel
11:00-11:30 Coffee Break/Commercial Exhibition/Abstract Exhibition
Session 3: Adipose Tissues In Obesity
11:30-12:00Visceral obesity and type 2 diabetes: time to align clinical practice/public health messages to the science Jean-Pierre Després
Canada
12:00-12:30Can molecular and functional signatures of adipose tissue guide clinical obesity subtyping?Assaf Rudich
Israel
12:30-13:00Lifestyle strategies for relieving the Cardiometabolic impact of obesity via adipose tissues' redistributionIris Shai
Israel
13:00-13:10Oral Abstract PresentationTBA
13:10-13:20Oral Abstract PresentationTBA
13:20-13:30Oral Abstract PresentationTBA
13:30-15:00Lunch
14:00-15:00MASTER CLASS: Chairs –
Lilach Malatskey
Israel Batya Kornboim Israel
Assessing and managing Cardiometabolic risk at the workplace: making lifestyle habits vital signs Jean-Pierre Després Canada,
14:00-15:00POSTER SESSION
15:00-15:20STATE OF THE ART - How Can we prevent weight regain?Luca Busetto
Italy
Session 4: Diabetes in special Populations & Situations
11:30-12:10A new era in Diabetes: evidence and experience with SGLT-2 inhibitors Paola Fioretto
Italy
12:10-12:30 Hypoglycemia as a risk factor for CVD? Ilana Harman-Boehm
Israel
12:30-12:50Elderly patients with Diabetes - Should we treat them differently? Anat Tsur
Israel
12:50-13:10GLP-1 system expression & activation during acute & stable Ischemic Heart Disease in patients with & without DiabetesMicha Rapaport
Israel
13:10-13:20Oral Abstract Presentation TBA
13:20-13:30Oral Abstract Presentation TBA
13:30-15:00Lunch
Session 5: Anti-Obesity Medication
15:20-15:40 STATE OF THE ART - Obesity as a Disease Lee Kaplan
USA
15:40-16:10Anti-Obesity medication – Present and Future Nick Finer
UK
16:10-16:40The roll of CNS in Anti-Obesity Medication Gabriella Liberman
Israel
16:40-17:00REAL WORLD DATA-Liraglutide 3mg for the Treatment of Obesity Naim Shehadeh
Israel
17:00-17:30What is the place of Anti-Obesity medication after bariatric surgery? Carel le Roux
Ireland
Session 6: Functional Food & DiaObesity
15:30-16:00Novel mechanisms for the metabolic actions of green tea polyphenolJeonga Kim
USA
16:00-16:30The food preservative Propionic Acid as a metabolic disruptor.Amir Tirosh
Israel
16:30-17:00TBATBA
Israel

Friday 24 Nov 2017

Program: Session 7 : Gut Microbiota and Diaobesity  
*** The Scientific Program is subject to changes
08:30-09:00Gut Microbiota manipulation in Obesity: promise and challengesEran Elinav
Israel
09:00-09:30Gut Microbiota: The importance of diversity Karine Clément
France
09:30-09:45Coffee Break/Commercial Exhibition/Abstract Exhibition
Session 8 : Childhood Obesity
09:45-10:15Sex hormones and brain reward in response to visual food cuesRam Weiss
Israel
10:15-10:45 Steroid Metabolomic Disease Signature of Nonsyndromic Childhood Obesity Zeev Hochberg
Israel
10:45-11:15 Impaired fasting glucose in children - what does it mean and should it be used? Emilia Hagman Sweden
Session 9 : Bariatric Surgery and Diaobesity
09:45-10:15Role of Gastro-Intestinal Hormones in Metabolic SurgeryGeltrude Mingrone
Italy
10:15-10:35Should we use anticoagulant after bariatric surgery? – Review on the new Israeli guidelines.Dorit Blickstein
Israel
10:35-10:50Can bariatric surgery reduce mortality?Orna Reges
Israel
10:50-11:05Hypoglycemia after bariatric surgery, how big is the problem?Dror Dicker
Israel
11:05-11:20How can we predict Diabetes Remission after Metabolic Surgery?Judith Aron Wisnewsky
France
11:20-12:40Does the Omega loop offer a better outcome than Roux-en-Y gastric bypass?Subhi M. Abu Abid
Israel
12:40-13:00 Should gastrectomy sleeve be the first line option for Bariatric Surgery?Hadar Spivak
Israel
13:00-13:20 PLENARY SESSION SUMMARY– What should be the 1st line Metabolic/Bariatric Surgery?Nahum Beglaibter
Israel
13:20-13:30 SUMMIT SUMMARY & FAREWELL Organizers
13:30-14:30Lunch